Edition:
India

Boiron SA (BOIR.PA)

BOIR.PA on Paris Stock Exchange

32.30EUR
15 Nov 2019
Change (% chg)

-- (--)
Prev Close
€32.30
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
10,480
52-wk High
€57.10
52-wk Low
€30.60

Latest Key Developments (Source: Significant Developments)

Boiron H1 Net Result Turns To Loss Of 0.4 Million Euros
Wednesday, 4 Sep 2019 

Sept 4 (Reuters) - BOIRON SA ::H1 SALES EUR 256.7 MILLION VERSUS EUR 280.5 MILLION YEAR AGO.H1 OPERATING INCOME EUR 6.0 MILLION VERSUS EUR 35.4 MILLION YEAR AGO.H1 NET LOSS GROUP SHARE EUR 0.4 MILLION VERSUS PROFIT EUR 21.6 MILLION YEAR AGO.OPERATING INCOME FOR 2019 WILL BE SIGNIFICANTLY LOWER THAN IN 2018..  Full Article

Boiron Sees 60% Of Its Activity Directly Affected By Change Of Reimbursement Rate Of Homeopathic Medicines
Friday, 28 Jun 2019 

June 28 (Reuters) - Boiron SA ::SAYS 60% OF ACTIVITY OF BOIRON GROUP WOULD BE DIRECTLY AFFECTED BY CHANGE OF REIMBURSEMENT RATE OF HOMEOPATHIC MEDICINES.  Full Article

Boiron: HAS Maintains Unfavorable Opinion Regarding Reimbursement Of Homeopathic Medicines
Friday, 28 Jun 2019 

June 28 (Reuters) - BOIRON SA ::HAUTE AUTORITE DE SANTE (HAS) HAS MAINTAINED ITS UNFAVORABLE OPINION REGARDING THE REIMBURSEMENT OF HOMEOPATHIC MEDICINES.SAYS 60% OF THE ACTIVITY OF THE BOIRON GROUP WOULD BE DIRECTLY AFFECTED BY A CHANGE OF THE REIMBURSEMENT RATE OF HOMEOPATHIC MEDICINES nFWN23Y17B.  Full Article

Boiron asks regulator to suspend trading in shares after media leaks
Thursday, 27 Jun 2019 

June 27 (Reuters) - Boiron SA ::SUSPENSION OF TRADING OF SHARES HAS BEEN REQUESTED TO AMF TODAY.DUE TO LEAK IN MEDIA, CONTENT OF 'HAS' OPINION REGARDING UPHOLDING OF REIMBURSEMENT OF HOMEOPATHIC MEDICINES HAS BEEN MADE PUBLIC, EVEN BEFORE BEING COMMUNICATED TO LABORATOIRES BOIRON.THIS MARKS A NEW VIOLATION OF RULES OF EVALUATION PROCEDURE THAT SERIOUSLY HARMS COMPANY, ITS EMPLOYEES AND ITS SHAREHOLDERS.  Full Article

Boiron Expects 2019 Operating Income To Be Lower YoY
Friday, 26 Apr 2019 

April 26 (Reuters) - BOIRON SA ::Q1 REVENUE EUR 143.3 MILLION VERSUS EUR 159.4 MILLION YEAR AGO.WE EXPECT 2019 OPERATING INCOME TO BE LOWER THAN IN 2018.  Full Article

Boiron FY Operating Income Down At EUR 106.0 Million
Wednesday, 13 Mar 2019 

March 13 (Reuters) - BOIRON SA ::FY OPERATING INCOME EUR 106.0 MILLION VERSUS EUR 125.0 MILLION YEAR AGO.TO PROPOSE DISTRIBUTION OF A DIVIDEND OF €1.45 PER SHARE.FY SALES EUR 604.2 MILLION VERSUS EUR 617.5 MILLION YEAR AGO.FY NET PROFIT GROUP SHARE EUR 57.5 MILLION VERSUS EUR 78.2 MILLION YEAR AGO.  Full Article

Boiron Q1 Revenue Broadly Stable At 159.4 Million Euros
Thursday, 26 Apr 2018 

April 26 (Reuters) - BOIRON SA ::TURNOVER IN Q1 OF 2018 IS ALMOST STABLE (-0.5%) IN COMPARISON TO Q1 OF 2017.Q1 REVENUE EUR 159.4 MILLION VERSUS EUR 160.3 MILLION YEAR AGO.  Full Article

Boiron FY Operating Income Down At 125.0 ‍​Million Euros
Wednesday, 14 Mar 2018 

March 14 (Reuters) - BOIRON SA ::FY OPERATING INCOME EUR 125.0 ‍​ MILLION VERSUS EUR 129.7 MILLION YEAR AGO.FY REVENUE EUR 617.5 ‍​ MILLION VERSUS EUR 614.5 MILLION YEAR AGO.FY NET RESULT GROUP SHARE EUR 78.2‍​ MILLION VERSUS EUR 77.7 MILLION YEAR AGO.WILL PROPOSE TO THE SHAREHOLDERS’ MEETING DISTRIBUTION OF DIVIDEND OF €1.60 PER SHARE FOR FY‍​.TO BOLSTER OUR INVESTMENTS IN PARTICULAR ON SITE OF MESSIMY AND ON SITE OF NEW LOGISTICS PLATFORM AT OLMES IN 2018‍​.  Full Article

Acquisition Of Trademarks And Patents From Alkantis For 2.495 Million Euros
Thursday, 14 Dec 2017 

Dec 14 (Reuters) - BOIRON SA ::ACQUISITION OF TRADEMARKS AND PATENTS.ACQUIRED FROM SWISS COMPANY ALKANTIS TRADEMARKS AND PATENTS RELATING TO ALKANTIS (ICE STERILE).PRICE OF SAID ACQUISITION FINANCED WITH OWN FUNDS AMOUNTS 2,495,000 EUROS..  Full Article

BRIEF-Boiron And Lehning Laboratories File Two Appeals Against Homeopathy Health Insurance Orders

* BOIRON AND LEHNING LABORATORIES SAID THEY HAVE FILED TWO APPEALS AT THE CONSEIL D'ETAT AGAINST RULINGS RESTRICTING HEALTH INSURANCE COVERAGE FOR HOMEOPATHIC DRUGS AND MEDICINES